qRT-PCR validation of the target genes confirmed highly significant RNA-seq differential expression: ASPM, PLK1, PLK4, CEP152, and Cyclin B1 had an increase in fold change of 5.29, 10.65, 10.97, 3.76, and 20.16 respectively ( Figure 3 Top).
← all excerpts
Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.
1
—
—